Differences in persistence by class of oral therapy for the treatment of type 2 diabetes by McGovern, AP, Hinton, H, Curtis, BH, van Brunt, K, Calderara, S, de Lusignan, S

What are the HbA(1c) thresholds for initiating insulin therapy in people with type 2 diabetes in UK primary care? by Hinton, W, McGovern, AP, Whyt, M, Curtis, BH, McCullough, K, van Brunt, K, Calderara, S, de Lusignan, S